IP Library Assignment 053636/0865
Patent Assignment
Reel/Frame 053636/0865

Change of Name

Recorded: 2020-08-28 Pages: 6
Assignor
QR PHARMA, INC.
Executed: 2019-04-09
Assignee
ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300, BERWYN, PENNSYLVANIA, 19312
Covered Properties (3)
(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8A-Hexahydropyrrolo[2,3-B]Indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Application: 16/994,881 →
Publication: US 2020/0375947
(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8A-Hexahydropyrrolo[2,3-B]Indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Application: 16/994,921 →
Publication: US 2021/0093610
(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8A-Hexahydropyrrolo[2,3-B]Indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Application: 16/994,924 →
Publication: US 2020/0375948
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 28, 2020
From: MACCECCHINI, MARIA
To: QR PHARMA, INC.
Reel/Frame 053625/0763 →